Company news

Cipher Pharmaceuticals Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Cipher Pharmaceuticals Reports First Quarter Results, Highlighted by Record Cash Per Share and Strong Financial Flexibility

May 11, 2023

Cipher Pharmaceuticals Schedules Q1 2023 Earnings Release and Conference Call

May 4, 2023

Cipher Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference

April 18, 2023

Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results

March 16, 2023

Cipher Pharmaceuticals Schedules Q4 2022 Earnings Release and Conference Call

March 10, 2023

Cipher Pharmaceuticals Announces Closing of New US$35 Million Credit Facility

March 1, 2023

Cipher Pharmaceuticals Reports Strong Third Quarter Results, Highlighted by USD$1.09 in Cash Per Share

November 10, 2022

Cipher Pharmaceuticals schedules Q3 2022 earnings release and conference call

October 26, 2022

Cipher Pharmaceuticals Strengthens Leadership Team with Appointment of New CFO

August 11, 2022

Cipher Pharmaceuticals Reports Second Quarter 2022 Financial Results

August 11, 2022

Cipher Pharmaceuticals Schedules Q2 2022 Earnings Release and Conference Call

August 5, 2022

Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders and Thanks Director Dr. John Mull

June 22, 2022

Cipher Pharmaceuticals Reports Strong First Quarter 2022 Financial Results

May 12, 2022

Cipher Pharmaceuticals Schedules Q1 2022 Earnings Release and Conference Call

May 9, 2022

Cipher Pharmaceuticals Announces Partner, Moberg Pharma's Regulatory Submission to FDA for North American Phase 3 Study

March 22, 2022

Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results

March 17, 2022

Cipher Pharmaceuticals Schedules Q4 2021 Earnings Release and Conference Call

March 11, 2022

Cipher Pharmaceuticals Announces Extension of Distribution and Supply Agreement with Sun Pharmaceutical Industries Inc.

March 10, 2022

Cipher Announces Third Quarter and Year-to-Date 2021 Financial Results

November 11, 2021

Cipher Pharmaceuticals Schedules Q3 2021 Earnings Release and Conference Call

November 3, 2021

Cipher Pharmaceuticals Announces Renewal of Normal Course Issuer Bid

September 8, 2021

Cipher Reports 30% Revenue Growth and 40% Adjusted EBITDA Growth in Second Quarter of 2021, Driven by Strength in Epuris and Absorica

August 12, 2021

Cipher Pharmaceuticals Schedules Q2 2021 Earnings Release and Conference Call

August 9, 2021

Cipher Pharmaceuticals Reports Voting Results From Annual Meeting of Shareholders

June 23, 2021

Cipher Pharmaceuticals Reports First Quarter 2021 Financial Results

May 13, 2021

Cipher Pharmaceuticals Schedules Q1 2021 Earnings Release and Conference Call

May 5, 2021

Cipher Pharmaceuticals Announces Automatic Repurchase Plan Pursuant to its Normal Course Issuer Bid

March 25, 2021

Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results

March 18, 2021

Cipher Pharmaceuticals Schedules Q4 2020 Earnings Release and Conference Call

March 10, 2021

Cipher Pharmaceuticals Enters into Co-Promotion Agreement with Verity Pharmaceuticals Inc.

February 10, 2021

Cipher Pharmaceuticals Receives Arbitration Award on Trulance®

January 15, 2021

Cipher Pharmaceuticals Reports Third Quarter 2020 Financial Results

November 12, 2020

Cipher Pharmaceuticals Schedules Q3 2020 Earnings Release and Conference Call

November 3, 2020

Cipher Pharmaceuticals Reports Voting Results for the Election of Directors

October 8, 2020

Cipher Pharmaceuticals Reports Second Quarter 2020 Financial Results

August 12, 2020

Cipher Pharmaceuticals Schedules Q2 2020 Earnings Release and Conference Call

July 27, 2020

Cipher Pharmaceuticals Appoints New Chief Financial Officer

July 2, 2020

Cipher Pharmaceuticals Reports First Quarter 2020 Financial Results

May 6, 2020

Cipher Pharmaceuticals Schedules Q1 2020 Earnings Release and Conference Call

April 27, 2020

Cipher Pharmaceuticals Receives Positive Ruling on Binding Arbitration with Upsher-Smith Laboratories

April 20, 2020

Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results

March 25, 2020

Notice of Cipher Pharmaceuticals Q4 2019 Conference Call

February 20, 2020

Cipher Pharmaceuticals Provides Update on Absorica Brand Extension Program with Sun Pharmaceutical

February 6, 2020

Cipher Pharmaceuticals Receives Notice of Termination from Bausch

January 20, 2020

Cipher Pharmaceuticals Reports Third Quarter 2019 Financial Results

November 7, 2019

Notice of Cipher Pharmaceuticals Q3 2019 Conference Call

October 24, 2019

Cipher Pharmaceuticals Receives Health Canada Approval For Trulance® (Plecanatide)

October 18, 2019

Cipher Pharmaceuticals Reports Second Quarter 2019 Financial Results

August 9, 2019

Notice of Cipher Pharmaceuticals Q2 2019 Conference Call

July 30, 2019

Cipher Pharmaceuticals Announces Management Change & Preliminary Q2 Financial Highlights

July 29, 2019

← Newer news releases · Older news releases →

Calls

The 5 newest of 14 calls. Every call is listed under its year.

Decks